The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies Article

Kusawake, Tomohiro, Kowalski, Donna, Takada, Akitsugu et al. (2017). The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies . 34(12), 10.1007/s12325-017-0643-3



Industry Collaboration International Collaboration

cited authors

  • Kusawake, Tomohiro; Kowalski, Donna; Takada, Akitsugu; Kato, Kota; Katashima, Masataka; Keirns, James J.; Lewand, Michaelene; Lasseter, Kenneth C.; Marbury, Thomas C.; Preston, Richard A.

publication date

  • December 2017

Digital Object Identifier (DOI)

volume

  • 34

issue

  • 12

research area